NCT04390880View on ClinicalTrials.gov

18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Prostate Cancer
Interventions
DRUG

18F-DCFPyL

Study participants will receive intravenous administration of 18F-DCFPyL and undergo a PET/CT imaging study. Patients may be reenrolled in the study, if 18F-DCFPyL PET/CT is performed for subsequent management decision.

Trial Locations (1)

90073

VA Greater Los Angeles Healthcare System, Los Angeles

All Listed Sponsors
lead

VA Greater Los Angeles Healthcare System

FED

NCT04390880 - 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter